Skip to main content
Access Resources

MJFF Publications

6701 - 6710 of 7616 Results
Title
Year
  • Year
  • 2014
  • 2014
  • 2014
  • 2014
  • 2014
  • 2014
  • 2014
  • 2014
  • 2014
  • 2014
  • RESTRICTED
    Title: Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents
    Journal Name: Journal of Comparative Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/cne.23583
    Citation Count: 112
  • RESTRICTED
    Title: Resistance of naturally secreted α‐synuclein to proteolysis
    Journal Name: The FASEB Journal
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1096/fj.13-245852
    Best OA location URL:
    Citation Count: 19
  • RESTRICTED
    Title: Essential Tremor in the Elderly and Risk for Dementia
    Journal Name: Journal of Neurodegenerative Diseases
    Publisher: Hindawi Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2014/328765
    Citation Count: 15
  • RESTRICTED
    Title: Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)
    Journal Name:
    Publisher:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier:
    Best OA location URL:
    Citation Count: 0
  • RESTRICTED
    Title: Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.82.10_supplement.p1.016
    Best OA location URL:
    Citation Count: 0
  • RESTRICTED
    Title: The BioFIND Study (Fox Investigation For New Discovery Of Biomarkers In Parkinson’s Disease): Design And Methodology (P4.043)
    Journal Name:
    Publisher:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier:
    Best OA location URL:
    Citation Count: 2
  • RESTRICTED
    Title: The BioFIND Study (Fox Investigation For New Discovery Of Biomarkers In Parkinson’s Disease): Design And Methodology (P4.043)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.82.10_supplement.p4.043
    Best OA location URL:
    Citation Count: 2
  • RESTRICTED
    Title: Evaluation of mild cognitive impairment subtypes in Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.25875
    Citation Count: 54
  • RESTRICTED
    Title: Treating Parkinson's disease in the 21st century: Can stem cell transplantation compete?
    Journal Name: Journal of Comparative Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/cne.23577
    Citation Count: 45
  • RESTRICTED
    Title: Large-scale resting state network correlates of cognitive impairment in Parkinson's disease and related dopaminergic deficits
    Journal Name: Frontiers in Systems Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnsys.2014.00045
    Citation Count: 84
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.